Cargando…

SFRP4 Reduces Atherosclerosis Plaque Formation in ApoE Deficient Mice

Secreted frizzled related protein 4 (SFRP4), a member of the SFRPs family, contributes to a significant function in metabolic and cardiovascular diseases. However, there is not enough evidence to prove the antiatherosclerosis effect of SFRP4 in ApoE knock-out (KO) mice. ApoE KO mice were fed a weste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guan, Hua, Liu, Ting, Liu, Miaomiao, Wang, Xue, Shi, Tao, Guo, Fengwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154090/ https://www.ncbi.nlm.nih.gov/pubmed/37143778 http://dx.doi.org/10.1155/2023/8302289

Ejemplares similares

C1QL1/CTRP14 Is Largely Dispensable for Atherosclerosis Formation in Apolipoprotein-E-Deficient Mice
por: Guan, Hua, et al.
Publicado: (2022)

Cortistatin reduces atherosclerosis in hyperlipidemic ApoE-deficient mice and the formation of foam cells
por: Delgado-Maroto, Virginia, et al.
Publicado: (2017)

Dystrophin deficiency reduces atherosclerotic plaque development in ApoE-null mice
por: Shami, Annelie, et al.
Publicado: (2015)

Annexin A5 reduces early plaque formation in ApoE -/- mice
por: Stöhr, Robert, et al.
Publicado: (2017)

MicroRNA-33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE(−/−) Mice
por: Horie, Takahiro, et al.
Publicado: (2012)

Inhibitory effects of Mycoepoxydiene on macrophage foam cell formation and atherosclerosis in ApoE-deficient mice
por: Xia, Xiaochun, et al.
Publicado: (2015)

Dietary Cocoa Powder Improves Hyperlipidemia and Reduces Atherosclerosis in apoE Deficient Mice through the Inhibition of Hepatic Endoplasmic Reticulum Stress
por: Guan, Hua, et al.
Publicado: (2016)

SAT-041 Testosterone Reduces Atherosclerosis and Plaque Specific Inflammatory Markers in the ApoE-/- Mouse Model
por: Bateman, Lauren, et al.
Publicado: (2020)

Loss of ADAMTS4 reduces high fat diet-induced atherosclerosis and enhances plaque stability in ApoE(−/−) mice
por: Kumar, Saran, et al.
Publicado: (2016)

Intranasal Delivery of E-Selectin Reduces Atherosclerosis in ApoE−/− Mice
por: Li, Xinhui, et al.
Publicado: (2011)

Overexpression of TGF-ß1 in Macrophages Reduces and Stabilizes Atherosclerotic Plaques in ApoE-Deficient Mice
por: Reifenberg, Kurt, et al.
Publicado: (2012)

Cordycepin stimulates autophagy in macrophages and prevents atherosclerotic plaque formation in ApoE(-/-) mice
por: Li, Xin, et al.
Publicado: (2017)

Metoprolol Reduces Proinflammatory Cytokines and Atherosclerosis in ApoE(−/−) Mice
por: Ulleryd, Marcus A., et al.
Publicado: (2014)

Thrombin inhibition by dabigatran attenuates atherosclerosis in ApoE deficient mice
por: Pingel, Simon, et al.
Publicado: (2014)

Bifunctional supramolecular nanofiber inhibits atherosclerosis by enhancing plaque stability and anti-inflammation in apoE(-/-) mice
por: Shang, Yuna, et al.
Publicado: (2020)

Tacrolimus reduces atherosclerotic plaque formation in ApoE(−/−) mice by inhibiting NLRP3 inflammatory corpuscles
por: Li, Xiao, et al.
Publicado: (2020)

Berberine derivatives reduce atherosclerotic plaque size and vulnerability in apoE(−/−) mice
por: Chen, Junwen, et al.
Publicado: (2014)

Corylin Inhibits Vascular Cell Inflammation, Proliferation and Migration and Reduces Atherosclerosis in ApoE-Deficient Mice
por: Chen, Chin-Chuan, et al.
Publicado: (2020)

Inhibition of Lipoprotein-Associated Phospholipase A2 Ameliorates Inflammation and Decreases Atherosclerotic Plaque Formation in ApoE-Deficient Mice
por: Wang, Wen-yi, et al.
Publicado: (2011)

Capsanthin Inhibits Atherosclerotic Plaque Formation and Vascular Inflammation in ApoE(−/−) Mice
por: Kim, Sungmin, et al.
Publicado: (2022)

Theranostic nanoplatform to target macrophages enables the inhibition of atherosclerosis progression and fluorescence imaging of plaque in ApoE(−/−) mice
por: Wang, Qi, et al.
Publicado: (2021)

Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome
por: Menu, P, et al.
Publicado: (2011)

Dickkopf‐3 Ablation Attenuates the Development of Atherosclerosis in ApoE‐Deficient Mice
por: Cheng, Wen‐Lin, et al.
Publicado: (2017)

Ribose-cysteine protects against the development of atherosclerosis in apoE-deficient mice
por: Kader, Tanjina, et al.
Publicado: (2020)

Mechanism of microRNA regulating the progress of atherosclerosis in apoE-deficient mice
por: Lou, Xiaoqian, et al.
Publicado: (2021)

Adenine-Induced Nephropathy Reduces Atherosclerosis in ApoE Knockout Mice
por: Scherler, Laeticia, et al.
Publicado: (2022)

Adipokine Chemerin Stimulates Progression of Atherosclerosis in ApoE(−/−) Mice
por: Liu, Huadong, et al.
Publicado: (2019)

Silence of TRIB3 Suppresses Atherosclerosis and Stabilizes Plaques in Diabetic ApoE(−/−)/LDL Receptor(−/−) Mice
por: Wang, Zhi-hao, et al.
Publicado: (2012)

Identification of the atherosclerosis phenotype in vivo by vascular duplex ultrasonography in ApoE-deficient dogs
por: Jia, Lingyun, et al.
Publicado: (2021)

GARP and GARP-Treated tDC Prevented the Formation of Atherosclerotic Plaques in ApoE(−/-) Mice
por: Cai, Yifan, et al.
Publicado: (2021)

Asperlin Inhibits LPS-Evoked Foam Cell Formation and Prevents Atherosclerosis in ApoE(−/−) Mice
por: Zhou, Yue, et al.
Publicado: (2017)

BMP-7 Treatment Increases M2 Macrophage Differentiation and Reduces Inflammation and Plaque Formation in Apo E(-/-) Mice
por: Singla, Dinender K., et al.
Publicado: (2016)

High phosphate diet reduces atherosclerosis formation in apolipoprotein E-deficient mice
por: Shiota, Asuka, et al.
Publicado: (2011)

Inhibitory effect of the combination therapy of simvastatin and pinocembrin on atherosclerosis in apoE-deficient mice
por: Sang, Hui, et al.
Publicado: (2012)

Effects of Icariin on Atherosclerosis and Predicted Function Regulatory Network in ApoE Deficient Mice
por: Zhang, Yibing, et al.
Publicado: (2018)

β-hydroxybutyrate Impedes the Progression of Alzheimer’s Disease and Atherosclerosis in ApoE-Deficient Mice
por: Krishnan, Manigandan, et al.
Publicado: (2020)

Smooth muscle cell specific NEMO deficiency inhibits atherosclerosis in ApoE(−/−) mice
por: Imai, Takashi, et al.
Publicado: (2022)

Effects of Shenlian extract on experimental atherosclerosis in ApoE-deficient mice based on ultrasound biomicroscopy
por: Guo, Yan, et al.
Publicado: (2016)

FAMP, a Novel ApoA‐I Mimetic Peptide, Suppresses Aortic Plaque Formation Through Promotion of Biological HDL Function in ApoE‐Deficient Mice
por: Uehara, Yoshinari, et al.
Publicado: (2013)

The Thyroid Receptor Modulator KB3495 Reduces Atherosclerosis Independently of Total Cholesterol in the Circulation in ApoE Deficient Mice
por: Mörk, Lisa-Mari, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lslg15a7e390kdnnrrhgfiv1jr